Where I see patients (1)
My work
Cutting-edge breast cancer care
Learn about the latest findings on breast cancer risk, screening and treatment from Dr. Esserman.
Should low-risk tumors still be called cancer?
Dr. Esserman explains how using a different term could reduce unnecessary worry over cancers that are unlikely to be life-threatening.
My reviews
Selected research
-
Tumor microenvironmental determinants of high-risk DCIS progression.
Research square
-
Reproductive rights in the United States: acquiescence is not a strategy.
Nature medicine
-
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.
Cancer research communications
Clinical trials
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Time to reach a durable COVID-19 level 4 or less or discharge at COVID-level 4 or lower (except for discharge to another hospital), and time to death (mortality). Data will be analyzed for 3 groups: - All - COVID-19 level...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-7070
4.8